Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 639-647

  Bechmann, Lars P ^a   Jochum, Christoph ^a   Kocabayoglu, Peri ^a   Sowa, Jan Peter ^a   Kassalik, Marco ^a   Gieseler, Robert K ^a,b   Saner, Fuat ^a   Paul, Andreas ^a   Trautwein, Christian ^c   Gerken, Guido ^a   Canbay, Ali ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Rodos BioTarget GmbH   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Acute liver failure; Apoptosis; Cell death

Indexed keywords

BILIRUBIN; CELL MARKER; CYTOKERATIN 18; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; M30; M65; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL DEATH; CONTROLLED STUDY; DATA COLLECTION METHOD; DEATH; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; LIVER INJURY; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN MODIFICATION; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; FEMALE; HUMANS; KERATIN-18; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 77956265378     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.04.029     Document Type: Article

References (27)

1. J.G. O'Grady Acute liver failure Postgrad Med J 81 2005 148 154
2. W.M. Lee, R.H. Squires Jr., S.L. Nyberg, E. Doo, and J.H. Hoofnagle Acute liver failure: summary of a workshop Hepatology 47 2008 1401 1415
3. W.C. Choi, W.C. Arnaout, F.G. Villamil, A.A. Demetriou, and J.M. Vierling Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure Korean J Intern Med 22 2007 93 100
4. S.E. Yantorno, W.K. Kremers, A.E. Ruf, J.J. Trentadue, L.G. Podesta, and F.G. Villamil MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure Liver Transpl 13 2007 822 828
5. J.D. Perkins Another formula to determine the prognosis of patients with acute liver failure Liver Transpl 15 2009 986 991
6. L.F. Pacheco-Moreira, E. Balbi, M. Enne, J. Roma, K. Paulino dos Santos, and T.B. Annunziata Liver transplantation for acute liver failure: trying to define when transplantation is futile Transplant proc 39 2007 3178 3181
7. L.E. Schmidt, and F.S. Larsen MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury Hepatology 45 2007 789 796
8. S. Singhal, S. Jain, I. Kohaar, M. Singla, R. Gondal, and P. Kar Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target Appl Immunohistochem Mol Morphol 17 2009 282 285
9. L.P. Bechmann, G. Marquitan, C. Jochum, F. Saner, G. Gerken, and A. Canbay Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure Liver Int 28 2008 713 716
10. H. Bantel, P. Ruck, M. Gregor, and K. Schulze-Osthoff Detection of elevated caspase activation and early apoptosis in liver diseases Eur J Cell Biol 80 2001 230 239
11. T.H. Ward, J. Cummings, E. Dean, A. Greystoke, J.M. Hou, and A. Backen Biomarkers of apoptosis Br J Cancer 99 2008 841 846
12. A. Greystoke, J. Cummings, T. Ward, K. Simpson, A. Renehan, and F. Butt Optimisation of circulating biomarkers of cell death for routine clinical use Ann Oncol 19 2008 990 995
13. C. Hiley, A. Fryer, J. Bell, R. Hume, and R.C. Strange The human glutathione S-transferases. Immunohistochemical studies of the developmental expression of Alpha- and Pi-class isoenzymes in liver Biochem J 254 1988 255 259
14. P.S. Kamath, and W.R. Kim The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
15. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
16. J.G. O'Grady, A.E. Gimson, C.J. O'Brien, A. Pucknell, R.D. Hughes, and R. Williams Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure Gastroenterology 94 1988 1186 1192
17. R.M. Taylor, T. Davern, S. Munoz, S.H. Han, B. McGuire, and A.M. Larson Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes Hepatology 44 2006 1589 1597
18. W. Bernal, and J. Wendon More on serum phosphate and prognosis of acute liver failure Hepatology 38 2003 533 534
19. J.G. O'Grady, G.J. Alexander, K.M. Hayllar, and R. Williams Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439 445
20. A.E. Rutherford, L.S. Hynan, C.B. Borges, D.G. Forcione, J.T. Blackard, and W. Lin Serum apoptosis markers in acute liver failure: a pilot study Clin Gastroenterol Hepatol 5 2007 1477 1483
21. P.A. Knolle, T. Germann, U. Treichel, A. Uhrig, E. Schmitt, and S. Hegenbarth Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells J Immunol 162 1999 1401 1407
22. A. Kuhla, C. Eipel, N. Siebert, K. Abshagen, M.D. Menger, and B. Vollmar Hepatocellular apoptosis is mediated by TNFα-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure Apoptosis 13 2008 1427 1438
23. J.Y. Lee, D.W. Chae, S.M. Kim, E.S. Nam, M.K. Jang, and J.H. Lee Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection J Viral Hepat 11 2004 130 135
24. X. Volkmann, M. Anstaett, J. Hadem, P. Stiefel, M.J. Bahr, and F. Lehner Caspase activation is associated with spontaneous recovery from acute liver failure Hepatology 47 2008 1624 1633
25. P.H. Krammer CD95's deadly mission in the immune system Nature 407 2000 789 795
26. I. Rodriguez, K. Matsuura, K. Khatib, J.C. Reed, S. Nagata, and P. Vassalli A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection J Exp Med 183 1996 1031 1036
27. A. Canbay, S. Friedman, and G.J. Gores Apoptosis: the nexus of liver injury and fibrosis Hepatology 39 2004 273 278